Closed Astghik-S closed 2 weeks ago
Dear @Astghik-S, Thank you for your request. We will take a closer look, but at first glance it seems that lipoprotein a could be included. Both fibrinogen and Creatine Kinase-MB are already in PRO or GO, though you would need to verify that the terms as given correlate with your needs:
GO:0005577 (http://purl.obolibrary.org/obo/GO_0005577) fibrinogen complex PR:000050466 (http://purl.obolibrary.org/obo/PR_000050466) fibrinogen complex (human) PR:000027247 (http://purl.obolibrary.org/obo/PR_000027247) cytosolic creatine kinase complex, MB-type PR:000050356 (http://purl.obolibrary.org/obo/PR_000050356) cytosolic creatine kinase complex, MB-type (human)
Please note that there are related creatine kinase terms in PRO, so these should be reviewed as well, in case another fits your needs better than the ones indicated.
Best regards, Darren
Dear @nataled, Thank you for your quick reply. I understand that fibrinogen is already represented in existing ontologies, but I have some concerns about reusing these terms given the distinctions in biomarker contexts.
In particular, I aim to represent both fibrinogen and fibrinogen complex as distinct entities within my ontology. In clinical biomarker applications, these entities carry different implications: fibrinogen typically refers to the soluble plasma protein measured in routine assessments for inflammation or cardiovascular risk, while fibrinogen complex often denotes aggregates or bound states relevant to clot formation and thrombotic risk. Similarly, distinctions also apply to other biomarkers, such as cytosolic creatine kinase complex, MB-type and cytosolic creatine kinase. I would appreciate hearing your perspective on this approach.
Best regards, Astghik
Dear Astghik,
Fibrinogen--the soluble plasma protein--is a complex, hence the name (PRO simply followed GO's nomenclature). That is, so far as I can tell, they are synonyms. What you are referring to as 'fibrinogen complex' seems to be fibrin(?), the clotting factor derived from processing of fibrinogen. I did see something else called 'fibrinogen complex' which appears to be a mixture of many proteins but chiefly fibrinogen. As it is a mixture of proteins and not a single entity, that latter usage would not be in scope for PRO.
I am unclear as to the distinctions you need regarding the other two requested terms. Can you provide a bit more information on these?
Best regards, Darren
Following up on lipoprotein(a)...this is in scope for PRO, as it is a complex of apolipoprotein a and apolipoprotein B-100. Do you need a human-specific version, or only something generic (to any species)?
Following up on lipoprotein(a)...this is in scope for PRO, as it is a complex of apolipoprotein a and apolipoprotein B-100. Do you need a human-specific version, or only something generic (to any species)?
Yes, human-specific is enough in this case
Dear Astghik,
Fibrinogen--the soluble plasma protein--is a complex, hence the name (PRO simply followed GO's nomenclature). That is, so far as I can tell, they are synonyms. What you are referring to as 'fibrinogen complex' seems to be fibrin(?), the clotting factor derived from processing of fibrinogen. I did see something else called 'fibrinogen complex' which appears to be a mixture of many proteins but chiefly fibrinogen. As it is a mixture of proteins and not a single entity, that latter usage would not be in scope for PRO.
I am unclear as to the distinctions you need regarding the other two requested terms. Can you provide a bit more information on these?
Best regards, Darren
Dear Darren,
I get your point. But I would say they are not the same. The terms "Fibrin" and "fibrinogen complex" are more acceptable as synonyms. Could you please review the terms once again and make a decision. And maybe you would like to have it as synonym. Please let me know about your decision.
Please consider to recheck "cytosolic creatine kinase complex, MB-type" and "cytosolic creatine kinase, MB".
Thank you!
Hi Astghik, A few comments/questions:
Generic (PR:000027247) Human (PR:000050356)
"CK-MB" "CK-MB (human)"
"CKMB" "CKMB (human)"
"creatine kinase MB" "creatine kinase MB (human)"
"creatine kinase-MB" "creatine kinase-MB (human)"
Let me know if there are other synonyms to add, or if there's a different thing you need.
Dear Darren,
Thank you very much for the informative answer!
Wherever I met Fibrinogen term ist was never written as "fibrinogen complex". For instance, here https://pubmed.ncbi.nlm.nih.gov/15837518/ , in the definition "Fibrinogen is a large, complex, fibrous glycoprotein with three pairs of polypeptide chains linked together by 29 disulfide bonds. " Correct me if I am mistaken,but as I understand the word "complex" is an adjective here and the term is called "fibrinogen" not "fibrinogen complex". So if zou prefer to keep the term "fibrinogan complex" then maybe it is a good idea to add "fibrinogen" as a synonym?
Thank you for creating lipoprotein(a) term. So it means we cannot yet use the term right?
The same issue with "creatine kinase MB". In the literature the term "creatine kinase MB" is commonly used and not "creatine kinase MB complex ". So I think adding it as a synonym resolves the problem.
Dear Astghik,
Thanks for using PRO! If you are satisfied that your needs are met, please go ahead and close this issue.
Best regards, Darren
Dear Darren,
Thank you very much! All good! I am closing the issue.
Best regards, Astghik
Dear PRO Maintainers,
As part of the OBO Foundry principles, we aim to ensure that terms are included in the most appropriate ontology and avoid duplication across ontologies wherever possible. We are working on a biomarker ontology (BMONT) and have identified several terms related to clinical and diagnostic metrics that may align well with the scope of PRO. Before proceeding to define these terms in our ontology, I wanted to reach out to ask if you would like to integrate any or all of the following terms into PRO.
The terms are as follows:
We believe they could add value to PRO if they are not already included.
Please let us know if you would like to incorporate any of these terms, or if you would prefer that we proceed with defining them in our own ontology. We are happy to collaborate and ensure these terms are defined in a way that aligns with OBO Foundry standards.
Thank you for considering our request. We look forward to hearing your thoughts and are open to any guidance you may have.
Best regards, Astghik Sargsyan Fraunhofer Institute for Algorithms and Scientific Computing SCAI